Publicaciones en las que colabora con RAFAEL SAN JUAN GARRIDO (100)

2024

  1. Current management of SARS-CoV-2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey

    Transplant Infectious Disease, Vol. 26, Núm. 2

  2. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  3. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

  4. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

  5. Invasive aspergillosis in liver transplant recipients in the current era

    American Journal of Transplantation, Vol. 24, Núm. 11, pp. 2092-2107

  6. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  7. Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

    Transplant Infectious Disease

  8. Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324

  9. Reduction of Instrumentation-Related Spine Surgical Site Infections After Optimization of Surgical Techniques. A Single Center Retrospective Analysis

    Global Spine Journal, Vol. 14, Núm. 2, pp. 438-446

  10. Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department

    Journal of Medical Virology, Vol. 96, Núm. 10

2023

  1. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  2. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  3. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  4. Comprehensive analysis of current epidemiology, clinical features and Prognostic Factors of puerperal endometritis: A retrospective cohort analysis

    European Journal of Obstetrics and Gynecology and Reproductive Biology: X, Vol. 18

  5. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

  6. Mortality due to carbapenemase-producing GNB in transplantation: Are risk scores useful?

    Transplant Infectious Disease

  7. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9

  8. Previous use of statins does not improve the outcome of bloodstream infection after kidney transplantation

    Transplant Infectious Disease, Vol. 25, Núm. 5

  9. Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 12, pp. 1485-1497

  10. Pyogenic liver abscesses in liver transplant recipients versus non-transplant population. Outcome and risk factors of patient survival

    Clinical Transplantation, Vol. 37, Núm. 6